| Product Code: ETC7551639 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The India postmenopausal vaginal atrophy drugs market import shipment experienced a negative CAGR from 2020-2024, indicating a slowing trend. The growth rate notably declined between 2023 and 2024, reflecting a significant loss in momentum during that period. Overall, the market showed signs of contraction and instability over the years.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Postmenopausal Vaginal Atrophy Drugs Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Postmenopausal Vaginal Atrophy Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 India Postmenopausal Vaginal Atrophy Drugs Market - Industry Life Cycle |
3.4 India Postmenopausal Vaginal Atrophy Drugs Market - Porter's Five Forces |
3.5 India Postmenopausal Vaginal Atrophy Drugs Market Revenues & Volume Share, By Therapy Type, 2021 & 2031F |
3.6 India Postmenopausal Vaginal Atrophy Drugs Market Revenues & Volume Share, By Drug Form, 2021 & 2031F |
4 India Postmenopausal Vaginal Atrophy Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about postmenopausal vaginal atrophy and its treatment options |
4.2.2 Growing elderly population in India |
4.2.3 Rise in disposable income leading to increased healthcare spending |
4.3 Market Restraints |
4.3.1 Lack of understanding and reluctance to seek treatment for postmenopausal vaginal atrophy |
4.3.2 Limited availability of specialized healthcare professionals for this condition |
4.3.3 High cost of postmenopausal vaginal atrophy drugs |
5 India Postmenopausal Vaginal Atrophy Drugs Market Trends |
6 India Postmenopausal Vaginal Atrophy Drugs Market, By Types |
6.1 India Postmenopausal Vaginal Atrophy Drugs Market, By Therapy Type |
6.1.1 Overview and Analysis |
6.1.2 India Postmenopausal Vaginal Atrophy Drugs Market Revenues & Volume, By Therapy Type, 2021- 2031F |
6.1.3 India Postmenopausal Vaginal Atrophy Drugs Market Revenues & Volume, By Estrogen Based Drugs, 2021- 2031F |
6.1.4 India Postmenopausal Vaginal Atrophy Drugs Market Revenues & Volume, By Non Estrogen Based Drugs, 2021- 2031F |
6.2 India Postmenopausal Vaginal Atrophy Drugs Market, By Drug Form |
6.2.1 Overview and Analysis |
6.2.2 India Postmenopausal Vaginal Atrophy Drugs Market Revenues & Volume, By Vaginal Gels, 2021- 2031F |
6.2.3 India Postmenopausal Vaginal Atrophy Drugs Market Revenues & Volume, By Creams, 2021- 2031F |
6.2.4 India Postmenopausal Vaginal Atrophy Drugs Market Revenues & Volume, By Tablets, 2021- 2031F |
6.2.5 India Postmenopausal Vaginal Atrophy Drugs Market Revenues & Volume, By Rings, 2021- 2031F |
6.2.6 India Postmenopausal Vaginal Atrophy Drugs Market Revenues & Volume, By Patches, 2021- 2031F |
7 India Postmenopausal Vaginal Atrophy Drugs Market Import-Export Trade Statistics |
7.1 India Postmenopausal Vaginal Atrophy Drugs Market Export to Major Countries |
7.2 India Postmenopausal Vaginal Atrophy Drugs Market Imports from Major Countries |
8 India Postmenopausal Vaginal Atrophy Drugs Market Key Performance Indicators |
8.1 Patient education and awareness programs attendance rates |
8.2 Number of healthcare facilities offering treatment for postmenopausal vaginal atrophy |
8.3 Prescription rates for postmenopausal vaginal atrophy drugs |
8.4 Patient adherence to prescribed treatment regimens |
8.5 Number of clinical trials for new postmenopausal vaginal atrophy drugs in India |
9 India Postmenopausal Vaginal Atrophy Drugs Market - Opportunity Assessment |
9.1 India Postmenopausal Vaginal Atrophy Drugs Market Opportunity Assessment, By Therapy Type, 2021 & 2031F |
9.2 India Postmenopausal Vaginal Atrophy Drugs Market Opportunity Assessment, By Drug Form, 2021 & 2031F |
10 India Postmenopausal Vaginal Atrophy Drugs Market - Competitive Landscape |
10.1 India Postmenopausal Vaginal Atrophy Drugs Market Revenue Share, By Companies, 2024 |
10.2 India Postmenopausal Vaginal Atrophy Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here